News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Stephen V Liu: The Phase 2b REZILIENT1 study of zipalertinib met its primary endpoint
Stephen V Liu/X
Feb 4, 2025, 10:31

Stephen V Liu: The Phase 2b REZILIENT1 study of zipalertinib met its primary endpoint

Stephen V Liu, Associate Professor of Medicine at Georgetown University, Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center, shared a post on X:

“The Phase 2b REZILIENT1 study of zipalertinib (CLN-081/TAS6417) met its primary endpoint of response rate in patients with EGFR exon 20 insertion mutation NSCLC.”

cancer OncoDaily Oncology Stephen V Liu ZIPALERTINIB
Special Coverage
Voices
Aug 11, 2025, 19:58
Ulrike Harjes: Laurence Zitvogel on Chemotherapy’s Role in Stimulating Anticancer Immunity
Insight
Aug 11, 2025, 19:44
Pan-Pacific Guidelines for Anti-CD38 Therapy in Relapsed/Refractory Multiple Myeloma
Voices
Aug 11, 2025, 19:36
Chadi Nabhan: Valuable Insights from Balazs Halmos on How to Treat Lung Cancer
Insight
Aug 11, 2025, 19:28
Weighing the Costs: Breast Cancer Trial Participation in the Deep South
Insight
Aug 11, 2025, 19:13
Alessandro Russo: Liquid Biopsy Advances to the Next Round
Insight
Aug 11, 2025, 19:08
Zhuoer Xie: OMG of OGM 
Voices
Aug 11, 2025, 19:01
Late-Breaking Abstract Submission for the SIOP Congress Closes on 19 August
Insight
Aug 11, 2025, 18:54
Sarah Sammons: Pearls for Talking to Breast Cancer Patients
Insight
Aug 11, 2025, 18:44
Paul Steven: Biomarker Endpoints - The Evolution of ctDNA and MRD in Oncology Trials
Voices
Aug 11, 2025, 18:42
Ready to Transform the Future of Lung Cancer Care? - IASLC
Societies
Aug 11, 2025, 18:06
Ghana Opens First Paediatric Palliative Care Service for Children With Cancer - World Child Cancer
Insight
Aug 11, 2025, 18:04
Ed Esplin: Real-World Evidence Supports Shift to Universal Genetic Testing in Breast Cancer Care